Invention Grant
- Patent Title: Gold optimized CAR t-cells
-
Application No.: US17683075Application Date: 2022-02-28
-
Publication No.: US11572566B2Publication Date: 2023-02-07
- Inventor: Benjamin Wang , Gusti Zeiner
- Applicant: Chimera Bioengineering, Inc.
- Applicant Address: US CA Menlo Park
- Assignee: Chimera Bioengineering, Inc.
- Current Assignee: Chimera Bioengineering, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: HelixIP LLP
- Main IPC: C12N15/63
- IPC: C12N15/63 ; C12N9/02 ; C12N9/96 ; C12Q1/6897 ; C12Q1/68

Abstract:
Control Devices are disclosed including RNA destabilizing elements (RDE), RNA control devices, and destabilizing elements (DE) combined with Chimeric Antigen Receptors (CARs) or other transgenes in eukaryotic cells. Multicistronic vectors are also disclosed for use in engineering host eukaryotic cells with the CARs and transgenes under the control of the control devices. These control devices can be used to optimize expression of CARs in the eukaryotic cells so that, for example, effector function is optimized. CARs and transgene payloads can also be engineered into eukaryotic cells so that the transgene payload is expressed and delivered after stimulation of the CAR on the eukaryotic cell.
Public/Granted literature
- US20220186233A1 Gold Optimized CAR T-cells Public/Granted day:2022-06-16
Information query
IPC分类: